Lillys CVOT Success With Trulicity Causes Bullish Outlook For Diabetes Franchise

Lilly’s CVOT Success With Trulicity Causes Bullish Outlook For Diabetes Franchise

13:32 EST 6 Nov 2018 | SCRIP

Lilly reported strong sales growth for many of its recently launched products, but news of the potentially differentiating REWIND cardiovascular...

More From BioPortfolio on "Lilly’s CVOT Success With Trulicity Causes Bullish Outlook For Diabetes Franchise"